![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tue, Apr 09, 2013 12:00 - InNexus Biotechnology Inc. (IXSBF: OTC Link) - Tier Change - The symbol, IXSBF, no longer is classified as OTC Pink Current. As of Tue, Apr 09, 2013, IXSBF resides in...
Fri, Mar 22, 2013 12:00 - InNexus Biotechnology Inc. (IXSBF: OTC Link) - Tier Change - The symbol, IXSBF, no longer is classified as OTC Pink Current. As of Fri, Mar 22, 2013, IXSBF resides in...
-- Key Data are New Releases for the Company Building on Milestones with Recent FDA Meetings and Technology Discoveries -- DENVER, April 20 /PRNewswire-FirstCall/ -- DXL625 monoclonal antibodies...
- Additional Presentations Underscore Potency, Binding Capabilities for Antibody Pipeline And Novel Technologies - SCOTTSDALE, Ariz., April 9 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc...
BRITISH COLUMBIA, Canada, March 25 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
- Company Receives Allowance of Patent Claims in the U.S. and in India - BRITISH COLUMBIA, Canada, March 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX...
- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock...
BRITISH COLUMBIA, Canada, Jan. 27 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), announced today that it has...
BRITISH COLUMBIA, Canada, Jan. 13 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
BRITISH COLUMBIA, Canada, Nov. 17 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com/), a drug development company...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions